Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Systemic amyloidoses].

Sara B Alvarez-Ruiz1, Irene García-Río, Esteban Daudén

  • 1Servicio de Dermatología, Hospital Universitario de La Princesa, Diego de León 62, 28006 Madrid, Spain. agarcia@aedv.es

Actas Dermo-Sifiliograficas
|February 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE Study.

Psoriasis (Auckland, N.Z.)·2026
Same author

Treatment-associated phenotype switching between psoriasis and atopic dermatitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Risk of infections in patients with psoriasis treated with biologic agents and new oral small molecules: BIOBADADERM registry.

The Journal of investigative dermatology·2026
Same author

Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study.

Dermatology and therapy·2026
Same author

Survival of Interleukin-17 and Interleukin-23 Inhibitors in Patients Previously Treated With a Tumor Necrosis Factor Inhibitor: Analysis of the Spanish Biobadaderm Registry.

Actas dermo-sifiliograficas·2026
Same author

Differential Expression of Galectin-1 and Galectin-9 in Immune-Mediated Inflammatory Diseases.

International journal of molecular sciences·2025

Amyloidoses involve abnormal protein deposits in tissues. Early diagnosis, especially skin manifestations, aids in managing these diverse systemic diseases.

Area of Science:

  • Biochemistry
  • Pathology
  • Genetics

Context:

  • Amyloidoses are a diverse group of diseases.
  • Characterized by extracellular fibrillar protein deposits.
  • Proteins are biochemically unrelated but share structural features.

Purpose:

  • To review amyloidoses based on clinical symptoms.
  • To highlight cutaneous and mucous membrane manifestations for early diagnosis.
  • To analyze organ involvement, diagnosis, prognosis, and treatment of systemic amyloidoses.

Summary:

  • Amyloidoses feature extracellular fibrillar protein deposits with characteristic Congo red birefringence and beta-pleated sheet structure.
  • Classified by clinical symptoms determined by the specific amyloid protein.
  • Cutaneous and mucous membrane involvement are key early diagnostic indicators.

Related Experiment Videos

Impact:

  • Facilitates early diagnosis of amyloidoses.
  • Aids in avoiding more aggressive diagnostic procedures.
  • Provides a comprehensive overview of systemic amyloidosis management.